EPCAM and hepatocellular carcinoma: Zhang et al. demonstrated that all-trans retinoic acid (ATRA) could induce differentiation of EpCAM+ HCC CSCs to decrease their tumorigenic potential by reducing CSC-related markers and increasing hepatocyte-specific genes.